BC Cancer Agency’s POG Program leads to a unique breakthrough in a patient’s treatment
The Personalized Onco-Genomics (POG) Program at the BC Cancer Agency has identified a life-altering treatment option for a patient with advanced cancer.
POG has given Trish Keating a new reason to hope as the genomic sequencing of her aggressive colorectal cancer identified a unique protein function at play. This critical detail pointed to an outside-of-the-box treatment option, which has dramatically reduced her cancer to barely detectable in just weeks. More...
Additional POG information for patients:
What is POG? The BC Cancer Agency’s Personalized Onco-Genomics (POG) program is a clinical research initiative that’s embedding genomic sequencing into real-time treatment planning for patients with incurable cancers.
What are the main goals of POG? The Program is setting out to decode the genome — the entire DNA inside the cell— of each patient’s cancer, to understand what is enabling it to grow and to develop treatment strategies to block its growth.
Who is eligible for POG? This research Program is for cancer patients being treated at the BC Cancer Agency (BC residents only) with metastatic disease.
Who do I contact for more information on POG? For more information on POG and eligibility, patients should speak to their medical oncologist.
How do patients get enrolled in POG?Patients should discuss their clinical treatment options, including clinical trials and POG with their oncologist.